Skip to content

Three-times-weekly vs Daily Iron Supplementation for primary prevention of Anemia in Pregnancy Living in Urban Area; An open-label, Randomized Controlled Trial

Three-times-weekly vs Daily Iron Supplementation for primary prevention of Anemia in Pregnancy Living in Urban Area; An open-label, Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20201013004
Enrollment
136
Registered
2020-10-13
Start date
2020-10-16
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia in Pregnancy Anemia in Pregnancy&#44

Interventions

received Triferdine 1 tab per oral three&#45
weekly (Monday&#44
Friday) 30 minutes before breakfast.,received Triferdine 1 tab per oral daily 30 minutes before breakfast.
weekly Iron Supplementation,Daily Iron Supplementation

Sponsors

none
Lead Sponsor
none,none,none,none
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: - Age >= 18 year-old - singleton - = 11 mg/dL, mcv >= 80, DCIP - negative - no thyroid disorder - no history of Triferdine allergy - understand and well-communicate Thai

Exclusion criteria

Exclusion criteria: - previous iron supplement in this pregnancy - previous blood transfusion - abnormal bleeding from any sites - thalassemia traits/disease or thyroid disorder - smoking or chronic lung disease - iron, iodine or folic acid allergy - poor compliance - aborted or delivered before 28 week-gestation - Forgot to take Triferdine more than 80%

Design outcomes

Primary

MeasureTime frame
Hb level at 28 week gestational age 14 week after receive iron supplement Hb level

Secondary

MeasureTime frame
drug compliance, iron side effect, iron rich foods consumption 14 week after receive iron supplement questionnaires

Countries

Thailand

Contacts

Public ContactPichamon Kanjana

Unaffiliated

pichamon.kaj@gmail.com+66863676867

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026